Tapering Venlafaxine

Introduction to Tapering

Venlafaxine should be tapered gradually by reducing the dose by 37.5mg every 1-2 weeks to minimize withdrawal symptoms, with slower reductions at lower doses, as recommended by the Mayo Clinic Proceedings 1
The American College of Physicians and other medical societies suggest that venlafaxine requires careful tapering when discontinuing treatment because it inhibits both serotonin and norepinephrine reuptake, with withdrawal symptoms potentially affecting both neurotransmitter systems 1, 2

The initial reduction should be from 150mg to 112.5mg daily for 1-2 weeks, followed by a decrease to 75mg daily for 1-2 weeks, then to 37.5mg daily for 1-2 weeks, and finally discontinuation, as outlined by the Mayo Clinic Proceedings 1
For patients who have been on venlafaxine for longer periods (>1 year), consider an even more gradual taper with smaller dose reductions (e.g., 25% of the most recent dose) and longer intervals between reductions (3-4 weeks), according to Praxis Medical Insights 3

Monitor for withdrawal symptoms at each dose reduction, including dizziness, headache, nausea, irritability, insomnia, and sensory disturbances, as these symptoms can be severe and may require intervention 1
If withdrawal symptoms become severe, consider returning to the previous dose temporarily, slowing the taper rate, or resuming tapering once symptoms have resolved, as recommended by the Mayo Clinic Proceedings 1
Non-pharmacological approaches, such as regular exercise, stress management techniques, and sleep hygiene practices, can be used to manage withdrawal symptoms, in addition to symptomatic treatment with NSAIDs, antihistamines, or anti-nausea remedies if needed 1

Tapering too quickly is the most common error and can lead to unnecessary suffering, as it may cause severe withdrawal symptoms, emphasizing the need for a gradual tapering schedule 1
Using a fixed percentage reduction throughout the taper rather than calculating from the most recent dose can also lead to errors, as it may not account for individual variations in response to the medication 1
Failing to recognize withdrawal symptoms and mistaking them for relapse of the original condition can delay appropriate treatment and worsen outcomes, highlighting the importance of careful monitoring and management 1